Cargando…
Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi
The proteoliposome derived from Vibrio cholerae O1 (PLc) is a nanoscaled structure obtained by a detergent extraction process. Intranasal (i.n) administration of PLc was immunogenic at mucosal and systemic level vs. V. cholerae; however the adjuvant potential of this structure for non-cholera antige...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582457/ https://www.ncbi.nlm.nih.gov/pubmed/23458379 http://dx.doi.org/10.1186/1471-2172-14-S1-S10 |
_version_ | 1782260568611094528 |
---|---|
author | Acevedo, Reinaldo Callicó, Adriana Aranguren, Yisabel Zayas, Caridad Valdés, Yolanda Pérez, Oliver García, Luis Ferro, Valerie A Pérez, José Luis |
author_facet | Acevedo, Reinaldo Callicó, Adriana Aranguren, Yisabel Zayas, Caridad Valdés, Yolanda Pérez, Oliver García, Luis Ferro, Valerie A Pérez, José Luis |
author_sort | Acevedo, Reinaldo |
collection | PubMed |
description | The proteoliposome derived from Vibrio cholerae O1 (PLc) is a nanoscaled structure obtained by a detergent extraction process. Intranasal (i.n) administration of PLc was immunogenic at mucosal and systemic level vs. V. cholerae; however the adjuvant potential of this structure for non-cholera antigens has not been proven yet. The aim of this work was to evaluate the effect of coadministering PLc with the Vi polysaccharide antigen (Poli Vi) of S. Typhi by the i.n route. The results showed that Poli Vi coadministered with PLc (PLc+Poli Vi) induce a higher IgA response in saliva (p<0.01) and faeces (p<0.01) than Poli Vi administered alone. Likewise, the IgG response in sera was higher in animals immunised with PLc+Poli Vi (p<0.01). Furthermore, IgG induced in sera of mice immunised with PLc+Poli Vi was similar (p>0.05) to that induced in a group of mice immunised by the parenteral route with the Cuban anti-typhoid vaccine vax-TyVi(®), although this vaccine did not induce a mucosal response. In conclusion, this work demonstrates that PLc can be used as a mucosal adjuvant to potentiate the immune response against a polysaccharide antigen like Poli Vi. |
format | Online Article Text |
id | pubmed-3582457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35824572013-03-08 Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi Acevedo, Reinaldo Callicó, Adriana Aranguren, Yisabel Zayas, Caridad Valdés, Yolanda Pérez, Oliver García, Luis Ferro, Valerie A Pérez, José Luis BMC Immunol Proceedings The proteoliposome derived from Vibrio cholerae O1 (PLc) is a nanoscaled structure obtained by a detergent extraction process. Intranasal (i.n) administration of PLc was immunogenic at mucosal and systemic level vs. V. cholerae; however the adjuvant potential of this structure for non-cholera antigens has not been proven yet. The aim of this work was to evaluate the effect of coadministering PLc with the Vi polysaccharide antigen (Poli Vi) of S. Typhi by the i.n route. The results showed that Poli Vi coadministered with PLc (PLc+Poli Vi) induce a higher IgA response in saliva (p<0.01) and faeces (p<0.01) than Poli Vi administered alone. Likewise, the IgG response in sera was higher in animals immunised with PLc+Poli Vi (p<0.01). Furthermore, IgG induced in sera of mice immunised with PLc+Poli Vi was similar (p>0.05) to that induced in a group of mice immunised by the parenteral route with the Cuban anti-typhoid vaccine vax-TyVi(®), although this vaccine did not induce a mucosal response. In conclusion, this work demonstrates that PLc can be used as a mucosal adjuvant to potentiate the immune response against a polysaccharide antigen like Poli Vi. BioMed Central 2013-02-25 /pmc/articles/PMC3582457/ /pubmed/23458379 http://dx.doi.org/10.1186/1471-2172-14-S1-S10 Text en Copyright ©2013 Acevedo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Proceedings Acevedo, Reinaldo Callicó, Adriana Aranguren, Yisabel Zayas, Caridad Valdés, Yolanda Pérez, Oliver García, Luis Ferro, Valerie A Pérez, José Luis Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi |
title | Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi |
title_full | Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi |
title_fullStr | Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi |
title_full_unstemmed | Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi |
title_short | Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi |
title_sort | immune adjuvant effect of v. cholerae o1 derived proteoliposome coadministered by intranasal route with vi polysaccharide from salmonella typhi |
topic | Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582457/ https://www.ncbi.nlm.nih.gov/pubmed/23458379 http://dx.doi.org/10.1186/1471-2172-14-S1-S10 |
work_keys_str_mv | AT acevedoreinaldo immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT callicoadriana immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT arangurenyisabel immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT zayascaridad immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT valdesyolanda immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT perezoliver immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT garcialuis immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT ferrovaleriea immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi AT perezjoseluis immuneadjuvanteffectofvcholeraeo1derivedproteoliposomecoadministeredbyintranasalroutewithvipolysaccharidefromsalmonellatyphi |